Product NDC: | 0069-0807 |
Proprietary Name: | SELZENTRY |
Non Proprietary Name: | Maraviroc |
Active Ingredient(s): | 150 mg/1 & nbsp; Maraviroc |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0807 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022128 |
Marketing Category: | NDA |
Start Marketing Date: | 20070806 |
Package NDC: | 0069-0807-60 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0069-0807-60) |
NDC Code | 0069-0807-60 |
Proprietary Name | SELZENTRY |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0069-0807-60) |
Product NDC | 0069-0807 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Maraviroc |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20070806 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | MARAVIROC |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |